StonvexLoading…
StonvexStonvexStonvexCore line items from MTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $1.35B | $271.03M | $2.96B | $2.69B |
Operating Income | $135.23M | $-209.82M | $559.96M | $763.56M |
Net Income | $23.25M | $-186.75M | $280.00M | $465.46M |
EPS (Diluted) | $0.65 | $-5.20 | $7.53 | $12.44 |
Total Assets | $5.60B | $5.76B | $5.78B | $5.76B |
Total Liabilities | $4.96B | $5.30B | $5.02B | $4.53B |
Cash & Equivalents | $384.74M | $581.47M | $440.29M | $467.03M |
Free Cash Flow OCF − CapEx | $429.27M | $244.27M | $319.68M | $547.18M |
Shares Outstanding | 35.87M | 35.91M | 37.20M | 37.41M |